Redpoint Bio Corporation, a development stage biotechnology company, focuses on the development of healthier foods and new approaches for the treatment of diabetes and obesity by understanding the biology of taste and its relationship to metabolism, satiety, and diabetes. It enters into a license and commercialization agreement with International Flavors and Fragrances Inc. for the development, manufacture, use, and commercialization of RP44, which is a component of the stevia plant that works as a sweetness enhancer amplifying the existing sugary sweetness in a food or beverage. The company is based in Philadelphia, Pennsylvania.
Industry, Sector and Symbol
Industry Commercial physical research
Sub-IndustryN/A
SectorMedical
Phone215-456-2312
Debt
Price-To-Earnings
Sales & Book Value
Annual SalesN/A
Profitability
Miscellaneous
EmployeesN/A
Next Earnings DateN/A
OptionableNot Optionable
Redpoint Bio (OTCMKTS:RPBC) Frequently Asked Questions
What is Redpoint Bio's stock symbol?
Redpoint Bio trades on the OTCMKTS under the ticker symbol "RPBC."
Has Redpoint Bio been receiving favorable news coverage?
Media headlines about RPBC stock have trended positive recently, InfoTrie reports. The research firm identifies negative and positive media coverage by monitoring more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. Redpoint Bio earned a media sentiment score of 2.7 on InfoTrie's scale. They also assigned news coverage about the company a news buzz of 1.0 out of 10, meaning that recent media coverage is extremely unlikely to have an effect on the company's share price in the near term.
Who are some of Redpoint Bio's key competitors?
Some companies that are related to Redpoint Bio include Iqvia (IQV), Incyte (INCY), EXACT Sciences (EXAS), Icon (ICLR), Charles River Laboratories Intl. (CRL), Exelixis (EXEL), PRA Health Sciences (PRAH), Syneos Health (SYNH), BTG (BTGGF), Medpace (MEDP), Intrexon (XON), Sorrento Therapeutics (SRNE), Eloxx Pharmaceuticals (ELOX), STARPHARMA HOLD/S (SPHRY) and Pieris Pharmaceuticals (PIRS).
What other stocks do shareholders of Redpoint Bio own?
Who are Redpoint Bio's key executives?
Redpoint Bio's management team includes the folowing people:
- Dr. R. Kyle Palmer Ph.D., Sr. Director of Discovery Research
How do I buy shares of Redpoint Bio?
Shares of RPBC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Redpoint Bio's stock price today?
One share of RPBC stock can currently be purchased for approximately $0.0001.
How big of a company is Redpoint Bio?
Redpoint Bio has a market capitalization of $7,992.00.
What is Redpoint Bio's official website?
How can I contact Redpoint Bio?
Redpoint Bio's mailing address is 7 GRAPHICS DRIVE, EWING NJ, 08628. The company can be reached via phone at 215-456-2312.
MarketBeat Community Rating for Redpoint Bio (OTCMKTS RPBC)
MarketBeat's community ratings are surveys of what our community members think about Redpoint Bio and other stocks. Vote "Outperform" if you believe RPBC will outperform the S&P 500 over the long term. Vote "Underperform" if you believe RPBC will underperform the S&P 500 over the long term. You may vote once every thirty days.
